Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S(DE:2TZ)
€2.26-0.02 (-1.74%)
DE:2TZ
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S financials statements
€2.26
At close:-0.02 (-1.74%)
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (2TZ) Ratios
0 Followers
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Ratios
DE:2TZ's free cash flow for Q3 2026 was ¥-9.29M. For the 2026 fiscal year, DE:2TZ's free cash flow was decreased by ¥-43.42M and operating cash flow was ¥34.13M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.59 | 2.35 | 2.03 | 2.17 | 2.64 |
| Quick Ratio | 1.34 | 1.89 | 1.54 | 1.74 | 2.01 |
| Cash Ratio | 0.23 | 1.04 | 0.66 | 0.86 | 0.94 |
| Solvency Ratio | 0.49 | 0.81 | 0.31 | 0.27 | 0.35 |
| Operating Cash Flow Ratio | 0.10 | 0.33 | 0.21 | 0.20 | 0.35 |
| Short-Term Operating Cash Flow Coverage | 7.96 | 42.70 | 8.42 | 6.66 | 8.04 |
| Net Current Asset Value | ¥ 2.56B | ¥ 3.69B | ¥ 2.97B | ¥ 3.64B | ¥ 3.87B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.03 | 0.03 | 0.00 |
| Debt-to-Equity Ratio | 0.01 | 0.00 | 0.05 | 0.04 | 0.01 |
| Debt-to-Capital Ratio | 0.01 | 0.00 | 0.05 | 0.04 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.04 | 0.02 | 0.00 |
| Financial Leverage Ratio | 1.65 | 1.37 | 1.55 | 1.56 | 1.42 |
| Debt Service Coverage Ratio | 33.33 | 38.50 | 9.64 | 8.94 | 8.31 |
| Interest Coverage Ratio | 271.71 | 63.86 | 30.60 | 95.44 | 295.08 |
| Debt to Market Cap | 0.00 | 0.00 | 0.03 | 0.04 | 0.02 |
| Interest Debt Per Share | 0.09 | 0.09 | 0.47 | 0.35 | 0.05 |
| Net Debt to EBITDA | -0.37 | -1.06 | -1.43 | -2.37 | -2.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 74.02% | 48.18% | 44.01% | 39.93% | 39.91% |
| EBIT Margin | 50.77% | 35.84% | 13.76% | 12.01% | 12.68% |
| EBITDA Margin | 53.12% | 37.57% | 15.34% | 13.42% | 14.35% |
| Operating Profit Margin | 50.63% | 35.13% | 13.34% | 11.88% | 12.55% |
| Pretax Profit Margin | 50.59% | 35.29% | 13.32% | 11.88% | 12.64% |
| Net Profit Margin | 43.34% | 30.51% | 12.00% | 10.45% | 11.13% |
| Continuous Operations Profit Margin | 42.92% | 30.32% | 11.78% | 10.59% | 11.39% |
| Net Income Per EBT | 85.67% | 86.45% | 90.08% | 87.92% | 88.12% |
| EBT Per EBIT | 99.91% | 100.47% | 99.85% | 100.01% | 100.71% |
| Return on Assets (ROA) | 18.23% | 20.70% | 9.65% | 8.48% | 8.48% |
| Return on Equity (ROE) | 30.02% | 28.42% | 14.95% | 13.21% | 12.08% |
| Return on Capital Employed (ROCE) | 34.66% | 32.28% | 15.68% | 14.36% | 13.07% |
| Return on Invested Capital (ROIC) | 29.17% | 27.66% | 13.70% | 12.61% | 11.59% |
| Return on Tangible Assets | 18.73% | 21.40% | 10.03% | 8.81% | 8.68% |
| Earnings Yield | 11.62% | 18.48% | 8.67% | 14.38% | 13.69% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.11 | 5.51 | 3.10 | 2.96 | 3.43 |
| Payables Turnover | 5.86 | 13.31 | 4.09 | 3.52 | 3.34 |
| Inventory Turnover | 1.13 | 2.94 | 2.94 | 3.47 | 2.72 |
| Fixed Asset Turnover | 4.31 | 5.24 | 5.70 | 5.63 | 4.65 |
| Asset Turnover | 0.42 | 0.68 | 0.80 | 0.81 | 0.76 |
| Working Capital Turnover Ratio | 1.53 | 2.06 | 2.27 | 2.09 | 1.86 |
| Cash Conversion Cycle | 378.76 | 162.70 | 152.69 | 124.97 | 131.13 |
| Days of Sales Outstanding | 117.33 | 66.18 | 117.77 | 123.23 | 106.28 |
| Days of Inventory Outstanding | 323.73 | 123.95 | 124.19 | 105.29 | 134.12 |
| Days of Payables Outstanding | 62.31 | 27.43 | 89.27 | 103.55 | 109.27 |
| Operating Cycle | 441.06 | 190.13 | 241.96 | 228.52 | 240.40 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.60 | 1.20 | 0.89 | 0.88 | 1.11 |
| Free Cash Flow Per Share | 0.45 | 1.05 | 0.71 | 0.74 | 0.90 |
| Dividend Paid and CapEx Coverage Ratio | 0.42 | 0.82 | 0.69 | 1.37 | 2.19 |
| Capital Expenditure Coverage Ratio | 3.89 | 7.85 | 4.89 | 6.28 | 5.43 |
| Operating Cash Flow Coverage Ratio | 7.37 | 33.93 | 2.11 | 2.63 | 25.70 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.13 | 0.08 | 0.08 | 0.12 |
| Free Cash Flow Yield | 1.87% | 6.69% | 4.81% | 9.50% | 12.38% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 8.61 | 5.41 | 11.53 | 6.96 | 7.30 |
| Price-to-Sales (P/S) Ratio | 3.73 | 1.65 | 1.38 | 0.73 | 0.81 |
| Price-to-Book (P/B) Ratio | 2.58 | 1.54 | 1.72 | 0.92 | 0.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 53.57 | 14.95 | 20.78 | 10.53 | 8.08 |
| Price-to-Operating Cash Flow Ratio | 39.79 | 13.05 | 16.53 | 8.85 | 6.59 |
| Price-to-Earnings Growth (PEG) Ratio | -1.92 | 0.04 | 0.81 | 0.58 | 0.45 |
| Enterprise Value Multiple | 6.66 | 3.33 | 7.60 | 3.04 | 3.40 |
| Enterprise Value | 17.39B | 9.15B | 9.58B | 3.37B | 3.37B |
| EV to EBITDA | 6.66 | 3.33 | 7.60 | 3.04 | 3.40 |
| EV to Sales | 3.54 | 1.25 | 1.17 | 0.41 | 0.49 |
| EV to Free Cash Flow | 50.78 | 11.34 | 17.50 | 5.92 | 4.84 |
| EV to Operating Cash Flow | 37.72 | 9.89 | 13.91 | 4.97 | 3.95 |
| Tangible Book Value Per Share | 8.82 | 9.75 | 8.11 | 8.03 | 8.21 |
| Shareholders’ Equity Per Share | 9.23 | 10.20 | 8.56 | 8.48 | 8.28 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.15 | 0.14 | 0.12 | 0.11 | 0.10 |
| Revenue Per Share | 6.39 | 9.50 | 10.67 | 10.73 | 8.98 |
| Net Income Per Share | 2.77 | 2.90 | 1.28 | 1.12 | 1.00 |
| Tax Burden | 0.86 | 0.86 | 0.90 | 0.88 | 0.88 |
| Interest Burden | 1.00 | 0.98 | 0.97 | 0.99 | 1.00 |
| Research & Development to Revenue | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 |
| SG&A to Revenue | 0.36 | 0.24 | 0.22 | 0.25 | 0.24 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Income Quality | 0.22 | 0.42 | 0.71 | 0.78 | 1.08 |
Currency in CNY
